Gerresheimer (OTCMKTS:GRRMF) Stock Price Up 16.7% – Here’s What Happened

Gerresheimer AG (OTCMKTS:GRRMF)’s stock price rose 16.7% during trading on Friday. The company traded as high as $33.90 and last traded at $33.90. Approximately 2,000 shares traded hands during mid-day trading, an increase of 541% from the average session volume of 312 shares. The stock had previously closed at $29.05.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Sanford C. Bernstein upgraded Gerresheimer from an “underperform” rating to a “market perform” rating in a research report on Wednesday, July 1st. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Gerresheimer in a research report on Tuesday, August 4th. Finally, UBS Group upgraded Gerresheimer from a “sell” rating to a “neutral” rating in a research report on Tuesday, August 4th. Four equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Gerresheimer Stock Up 16.7%

The company’s fifty day moving average price is $30.79 and its 200-day moving average price is $29.48.

About Gerresheimer

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems.